Cellectis S.A. (ALCLS.PA) - Stock Prices, Stock Peers & Analysis

Home
ALCLS.PA

Company Name	Cellectis S.A.
Symbol	ALCLS.PA
Currency	EUR
Price	2.065
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	143,887,166
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.888 - 3.44
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Andre Choulika Ph.D.
Website	https://www.cellectis.com

An error occurred while fetching data.

About Cellectis S.A.

Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies,